Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult with 5q-Related Spinal Muscular Atrophy Type 1 and Severe Spinal Deformity
Spinal muscular atrophy (SMA) is a hereditary neuromuscular disorder, typically caused by survival motor neuron 1 (SMN1) gene deletion in chromosome 5q resulting in loss of SMN protein. SMA type 1 progresses rapidly leading to increased mortality usually before the age of 2 years. Nusinersen, the fi...
Guardado en:
Autores principales: | Vasileios Papaliagkas, Nikolaos Foroglou, Petros Toulios, Maria Moschou, Maria Gavriilaki, Konstantinos Notas, Evangelia Chatzikyriakou, Georgia Zafeiridou, Marianthi Arnaoutoglou, Vasilios K. Kimiskidis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Karger Publishers
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd7d33fc23a84cec8040e955230bfb92 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Improvement in Fine Manual Dexterity in Children with Spinal Muscular Atrophy Type 2 after Nusinersen Injection: A Case Series
por: Minsu Gu, et al.
Publicado: (2021) -
A CASE OF NEONATAL SPINAL MUSCULAR ATROPHY WITH SEPSIS LIKE PRESENTATION
por: Oznur Yilmaz Gondal, et al.
Publicado: (2021) -
Nusinersen: Single-Centre Real-Life Experience in Type 1 Spinal Muscular Atrophy
por: Andreia Lomba, et al.
Publicado: (2021) -
Intrathecal interleukin-1β decreases sigma-1 receptor expression in spinal astrocytes in a murine model of neuropathic pain
por: Sheu-Ran Choi, et al.
Publicado: (2021) -
Manejo respiratorio en atrofia muscular espinal: Cambio de paradigma en la era de las nuevas terapias específicas
por: Palomino,María Angélica, et al.
Publicado: (2018)